# Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence

> **NCT00525291** · PHASE3 · COMPLETED · sponsor: **University of Giessen** · enrollment: 158 (actual)

## Conditions studied

- Fecal Incontinence

## Interventions

- **DEVICE:** Combination of EMG-biofeedback plus EMG-triggered AM-MF-stimulation
- **DEVICE:** EMG-biofeedback alone

## Key facts

- **NCT ID:** NCT00525291
- **Lead sponsor:** University of Giessen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 158 (ACTUAL)
- **Last updated:** 2009-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00525291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00525291, "Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00525291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*